Brief Communication abstract


Nature Genetics 39, 1065 - 1067 (2007)
Published online: 29 July 2007 | doi:10.1038/ng2091

Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus

Min Ae Lee-Kirsch1, Maolian Gong2,14, Dipanjan Chowdhury3,14, Lydia Senenko1,14, Kerstin Engel1,14, Young-Ae Lee2,4,14, Udesh de Silva5, Suzanna L Bailey5, Torsten Witte6, Timothy J Vyse7, Juha Kere8, Christiane Pfeiffer9, Scott Harvey10, Andrew Wong7, Sari Koskenmies11,12, Oliver Hummel2, Klaus Rohde2, Reinhold E Schmidt6, Anna F Dominiczak13, Manfred Gahr1, Thomas Hollis5, Fred W Perrino10, Judy Lieberman3 & Norbert Hübner2

Top

TREX1 acts in concert with the SET complex in granzyme A–mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 times 10-7). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.

Top
  1. Klinik für Kinder- und Jugendmedizin, Technische Universität Dresden, 01307 Dresden, Germany.
  2. Max Delbrück Center for Molecular Medicine (MDC), 13125 Berlin-Buch, Germany.
  3. CBR Institute for Biomedical Research, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02125, USA.
  4. Charité - Universitätsmedizin Berlin, Pediatric Pneumology and Immunology, Campus Virchow-Klinikum, 13353 Berlin, Germany.
  5. Center for Structural Biology, Department of Biochemistry, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157, USA.
  6. Medizinische Hochschule Hannover, Klinische Immunologie, 30625 Hannover, Germany.
  7. Imperial College, Faculty of Medicine, Section of Rheumatology and Molecular Genetics, Hammersmith Hospital, London W12 0NN, UK.
  8. Karolinska Institute, Department of Biosciences and Nutrition, and Clinical Research Centre, 14157 Huddinge, Sweden.
  9. Klinik für Dermatologie, Technische Universität Dresden, 01307 Dresden, Germany.
  10. Department of Biochemistry, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157, USA.
  11. University of Helsinki, Department of Medical Genetics, 00014 Helsinki, Finland.
  12. Department of Dermatology, 00014 Helsinki, Finland.
  13. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
  14. These authors contributed equally to this work.

Correspondence to: Min Ae Lee-Kirsch1 e-mail: minae.lee-kirsch@uniklinikum-dresden.de

Correspondence to: Norbert Hübner2 e-mail: nhuebner@mdc-berlin.de


Extra navigation

Subscribe to Nature Genetics

Subscribe

natureproducts


ADVERTISEMENT